Isabel Machuca

Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms

Elizabeth Temkin, Julián Torre‐Cisneros, Bojana Beovič et al. · Antimicrobial Agents and Chemotherapy · 2016 · 250 citations · Full text

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto et al. · Mayo Clinic Proceedings · 2016 · 115 citations

Predictive Model, Klebsiella Pneumoniae, Healthcare-associated Infection +8

Risks of Infection and Mortality Among Patients Colonized With Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Validation of Scores and Proposal for Management

Ángela Cano, Belén Gutiérrez‐Gutiérrez, Isabel Machuca et al. · Clinical Infectious Diseases · 2017 · 105 citations · Full text

Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems

Isabel Machuca, Belén Gutiérrez‐Gutiérrez, Irene Gracia-Ahufinger et al. · Antimicrobial Agents and Chemotherapy · 2017 · 74 citations · Full text

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron et al. · The Lancet HIV · 2020 · 68 citations · Full text

Primary Immunodeficiency, Treatment And Prevention, Human Retrovirus +9